Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 73.58 +0.82%   SPY: 165.74 +0.79%
Quote Spy MYL NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


Mylan (MYL)

@ Jun-18
Click the portfolio to add MYL:
Close [X]
+ Add MYL to Portfolio
  
  Last Trade: $31.87 +0.33 (1.05%)
  Volume: 3,417,262 70% of avg daily volume
       
  Avg Volume: 4,905,358
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 31.41 - 31.96
  Open: 31.62
  Previous Close: 31.54
  52-wk Range: 20.50 - 32.27
  Market Cap: 12.0B
  P/E: 20.9
  Div Yield: $0.00 (0.00%)
Indexes
Cardiology Stocks (+1.3%)
Generic Drug Stocks (+1.4%)
Medical Aesthetics a... (+0.9%)
Spy MYL

? Pro holders
? Member holders
? Items submitted
Additional MYL resources



Customize Links
To see which Pros and tickerspy members own MYL Sign up now
Latest MYL Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

Valeant Eyes Bausch & Lomb
FRX  MYL  AGN  VRX  
Linked by Investopedia Stock Analysis - May 28, 09:30AM from (www.investopedia.com)
Canadian pharmaceutical company Valeant has made a name for itself through acquisitions. On May 27 it announced that it was  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
A Good Deal For Actavis, But Warner Chilcott Goes A Little Cheap
MYL  ACT  VRX  WCRX  
Linked by Investopedia Stock Analysis - May 21, 02:00PM from (www.investopedia.com)
Actavis gets a very useful asset, while Warner Chilcott shareholders get a decent exit.  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Pharma M&A – Actavis to Acquire Warner Chilcott
FRX  MYL  TEVA  ACT  VRX  WCRX  
Linked by Benzinga.com - May 20, 11:32AM from (www.benzinga.com)
On Monday, generic drug maker Actavis Inc. (NYSE: ACT) announced plans to purchase specialty pharmaceutical company Warner  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
DealBook: Actavis to Buy Warner Chilcott in All-Stock Deal
MYL  VRX  WCRX  
Linked by NYTimes - May 20, 08:16AM from (dealbook.nytimes.com)
Actavis, a maker of generic drugs, agreed to buy the specialty pharmaceutical company Warner Chilcott for about $5 billion  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Teva Still Too Cheap, But Still Too Uncertain
MYL  TEVA  ACT  NVS  
Linked by Investopedia Stock Analysis - May 03, 01:45PM from (www.investopedia.com)
Teva's present-day momentum is weak, but the value could appeal to patient long-term investors.  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Mylan Reports a 19% Increase in First Quarter 2013 Adjusted Diluted EPS to $0.62
MYL  
Posted by PR Newswire - May 02, 04:05PM

PITTSBURGH, May 2, 2013 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced its  more ...
Post a comment

Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Actavis Seen Selling for Higher Valuation: Real M&A
MYL  PFE  ACT  VRX  
Linked by Bloomberg - April 30, 06:47PM from (www.bloomberg.com)
Actavis Inc. (ACT), the generic drugmaker whose merger negotiations with Valeant (VRX) Pharmaceuticals International Inc.  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
F.D.A. Approves Raptor Drug for Form of Cystinosis
JPM  MYL  
Linked by NYTimes - April 30, 03:38PM from (www.nytimes.com)
Procysbi from Raptor Pharmaceutical highlights the role that foundations can play in drug development, but it could also  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
J.P. Morgan Says Apple and Other Underperforming Stocks Should Lead the Market in Second Quarter
JPM  MYL  AAPL  ESRX  CHS  CHKP  BRCM  TASR  
Linked by 24/7 Wall St. - April 05, 08:40AM from (247wallst.com)
With earnings season kicking off next week and a plethora of challenging global news hitting the tape, investors are becoming  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
UBS Picks the Eight Top Stocks to Buy Now
CMI  F  MYL  HD  LLTC  SBUX  GILD  MCK  UBS  
Linked by 24/7 Wall St. - March 12, 08:25AM from (247wallst.com)
For anybody that has missed the big stock market rally, it can be very disheartening to watch as anchors on every business  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9 ... 14



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource